Fig. 6.
Tumor growth curves (relative tumor volume) in MAXF1322 xenograft model. Median relative tumor volume (%) was assessed in the MAXF1322 xenograft model with different doses of indatuximab ravtansine, paclitaxel (taxol), DM4 and nBT062.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.